Marinobufagenin, left ventricular geometry and cardiac dysfunction in end-stage kidney disease patients.

Davide BolignanoSalvatore De RosaMarta GrecoPierangela PrestaGemma PatellaGiuseppina CruglianoJolanda SabatinoAntonio StrangioLetizia Rosa RomanoAlessandro ComiPaola CianfroneMichele AndreucciFrancesco DragoneCiro IndolfiDaniela Patrizia FotiGiuseppe Coppolino

Published in: International urology and nephrology (2022)

Deranged plasma MBG levels in ESKD patients on chronic dialysis reflect alterations in LV structure and function. MBG may, thus, candidate as a novel biomarker for improving cardiac assessment in this high-risk population.

Keyphrases

end stage renal disease
left ventricular
chronic kidney disease
ejection fraction
newly diagnosed
peritoneal dialysis
heart failure
prognostic factors
oxidative stress
acute myocardial infarction
aortic stenosis
acute coronary syndrome
hypertrophic cardiomyopathy
transcatheter aortic valve replacement